Titan Bio-Tech Board of Directors

Get the latest insights into the leadership at Titan Bio-Tech. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Naresh Kumar Singla Managing Director
Mr. Suresh Chand Singla Managing Director
Mr. Raja Singla Whole Time Director
Mr. Shivom Singla Whole Time Director
Mr. Udit Singla Whole Time Director
Mrs. Manju Singla Director
Ms. Supriya Singla Director
Mr. Rohit Jain Independent Director
Mr. Abhishek Agarwal Independent Director
Mr. Brijesh Kumar Singh Independent Director
Mr. Dhairya Madan Independent Director

Titan Bio-Tech Share price

TITANBIO

748.95

25.45 (3.52%)
Last updated on 1 Sep, 2025 | 15:44 IST
BUYSELL
Today's High

795.85

Today's Low

732.30

52 Week Low

373.65

52 Week High

1017.85

The current prices are delayed, login to your account for live prices

Titan Bio-Tech FAQs

The board at Titan Bio-Tech consists of experienced professionals, including Mr. Naresh Kumar Singla , Mr. Suresh Chand Singla , and others, overseeing the company’s strategic and corporate governance.

Directors at Titan Bio-Tech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Naresh Kumar Singla is the current chairman at Titan Bio-Tech.

Executive directors at Titan Bio-Tech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Titan Bio-Tech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Titan Bio-Tech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.